Navigation Links
Sharps Compliance Corp. Announces Appointment of Al Aladwani as its Senior Vice President of Operations
Date:3/24/2008

HOUSTON, March 24 /PRNewswire-FirstCall/ -- Sharps Compliance Corp. (OTC Bulletin Board: SCOM) ("Sharps" or the "Company"), leading providers of cost-effective disposal solutions for small quantity generators of medical waste, announced today the appointment of Al Aladwani to the position of Senior Vice President of Operations. Mr. Aladwani joins Sharps effective immediately from Generic Medical Devices ("GMD"), a developer and manufacturer of medical devices, where he served as Vice President of Operations.

Dr. Burton J. Kunik, the Company's Chairman, Chief Executive Officer and President commented, "Al is joining Sharps at a time when we are rapidly building our operational infrastructure in order to facilitate the Company's significant expected growth. The number and size of the opportunities that we are pursuing requires us to measurably expand our physical footprint, and create a larger and leaner workflow for our products. We are very excited to have a professional with Al's capabilities and operations experience on the Sharps Compliance team."

Prior to GMD, Mr. Aladwani served in various operational roles with Cyberonics, Inc., Creos Medical and Ohmeda Medical. Mr. Aladwani has extensive medical device, FDA and ISO experience as well as lean manufacturing certification from Purdue University. Mr. Aladwani graduated in 1978 with a BA in Business Administration from Kuwait University.

Sharps targets many markets including pharmaceutical manufacturing, retail pharmacy, hospitality and home healthcare as well as cities and municipalities for its mail back disposal system for small quantity generators of sharps waste such as syringes.

About Sharps Compliance Corp.

Headquartered in Houston, Texas, Sharps Compliance is a leading provider of cost-effective disposal solutions for small quantity generators of medical waste. The Company's flagship product, the Sharps Disposal by Mail System(R), is a cost-effective and easy-to-us
'/>"/>

SOURCE Sharps Compliance Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Sharps Compliance Corp. to Present at the RedChip Small-Cap Investor Conference in Scottsdale, Arizona
2. Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008
3. Sharps Compliance Corp. Announces New Senior Vice President of Sales and Marketing
4. Sharps Compliance Corp. Announces First Quarter Fiscal Year 2008 Conference Call and Webcast
5. Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post
6. Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market
7. Vion Pharmaceuticals Regains NASDAQ Listing Compliance
8. Sensor necklace aims to increase elderly and clinical trial participant drug compliance
9. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
10. Highlands Acquisition Corp. Receives Non-Compliance Letter From Amex
11. Vendormate Eases Compliance Burden for Healthcare Vendors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...orporation Executive, Robert J. Reilly, Joins Aeth...on Inc.,( http://www.aethon.com ), the leading dev...n logistics, today announced that Robert J. Reilly...- Chief Financial Officer., Reilly, who was most ...esson Corporation,s Specialty Pharmacy Division, b...
(Date:7/25/2008)...25 /PRNewswire/ -- The Elekta Family of Companies ...t solutions at the 2008,American Association of Ph...trating how the joint forces of Elekta, IMPAC and ...planning and delivery solutions that,streamline th...for,patients, as well as enhance clinician efficie...
(Date:7/25/2008)...f., July 25 /PRNewswire/ -- AutoGenomics, Inc. tod...ement on Form S-1 with the,Securities and Exchange...c,offering of shares of its common stock. The numb... which are expected to be offered by,AutoGenomics,...not yet been,determined., J.P. Morgan Securities ...
(Date:7/25/2008)...ughest for those trying to drop pounds, study find...- Anyone who has avoided Monday morning weigh-ins ...ieter,s friend. , Now, researchers have some sc...s being their undoing: Most people do eat more on ...ht. , "Weekend indulgences can wreak havoc on w...
Breaking Medicine News(10 mins):Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3
...r and death from cancer among Chinese women is ris...ai// Disease Prevention and Control Centre Friday....ghai urban area has almost doubled in 20 years and...ontracting the disease, the center reports. The l...
...rm Biocon Ltd Thursday announced the launch of ren...and reducing// the risk of such disease. As the l...ontinent, the company has set up a nephrology divi...odapt (Mycophenolate Mofeti), Tacrograf (Tacrolimu...
...a world-renowned California-based biomedical facil...ome up with a chemical// that would help prevent r...synthetic compound, called MTIP, blocks the action...-Releasing Factor (CRF), according to a joint anim...
...the food chain via the Bernard Matthews plant, whi...ird flu in early February this year. The Public ...ost 850 tons of turkey had to pass through the pla... had occurred in the interim period between outbre...
Other Medicine News:Health News:Biocon Unveils Renal Therapies for Kidney Disorders 2
(Date:7/24/2008)...re/ -- There are a record 301,new medicines being ...,report released here today during a briefing that...lnesses have on patients, their families,and soci...million American,adults. The briefing, led by the ...ca (PhRMA), featured Emmy Award-winning actor Joey...
(Date:7/24/2008)...-- MacroChem Corporation (OTC,Bulletin Board: MACM...ial,involving 37 patients who completed a 48-week,... study of EcoNail, a topical antifungal,lacquer fo...e composite,primary efficacy endpoint of the trial...(negative fungal culture and negative KOH) and cle...
(Date:7/23/2008)...armaceuticals (SPI) has filed,an Investigational N...testing of a proprietary formulation of ebselen fo...oss or ototoxicity. The oral capsule,containing eb...lung cancer,and head and neck cancer patients rece...second development program for SPI to enter clinic...
(Date:7/23/2008)...Code BioPharmaceutics, Inc.,an emerging biopharma...,results demonstrating the utility of their lead d...chronic blood disorder paroxysmal nocturnal,hemogl...nted at the XXII,International Complement Workshop...only treatment currently available for PNH patient...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2MIT works toward novel therapeutic device 4265 1MIT works toward novel therapeutic device 4265 2MIT works toward novel therapeutic device 4265 3Endobronchial valve significantly improves emphysema 912 1Endobronchial valve significantly improves emphysema 912 2Kidney Care Community Voices Strong Support for Kidney Patients Right to Choose 4261 1Kidney Care Community Voices Strong Support for Kidney Patients Right to Choose 4261 2Kidney Care Community Voices Strong Support for Kidney Patients Right to Choose 4261 3New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 1New Study Shows Lower Costs Increased Consumer Engagement in Account Based Health Plans 4257 2
...NESS WIRE)--Jun 19, 2007 - Geron,Corporation (Nasd...,the scalable production, survival following engra...infarcted rats was presented,today for GRNCM1, the...therapeutic for heart failure, at the Internationa...eting in Cairns,Australia., The presentation was ...
...SS WIRE)--Jun 19, 2007 - Javelin,Pharmaceuticals (...ate Rylomine(TM) (intranasal morphine) successfull...e Pain Intensity Difference,(SPID) scores over 0-2...tal Phase 3 studies, patients with moderate-to-sev...ven 7.5 mg Rylomine every,hour as needed, 15 mg Ry...
Other Medicine Technology:Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 2Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 3Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 4Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 5Research Documents Scalable Production, Survival Following,Engraftment and Positive Impact on Cardiac Function in Infarcted,Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for,Heart Failure 6Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 2Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 3Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 4
Blunt Tapered Tip in stainless steel.
...ipurpose gamma camera is designed for SPECT and PE...mbines the high-energy and PET imaging capability ...ECT and planar imaging, all in one unit.,The ...nd general nuclear medicine applications well beyo...
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM
AXIOM Artis FA is a universal floor-mounted angiographic C-arm system whose flexible system architecture is ideal for vascular and non-vascular diagnostics and interventions. It provides complete erg
Medicine Products: